TSC2 and neoplasm: Similar results were seen in Tsc2-deficient TTJ cells, with B7-H3 inhibition suppressing tumor growth by >50% (Supplementary Fig. 4a) and approximately doubling tumor-free survival (Supplementary Fig. 4b).